oncology_no_border

Pharmafocus: Advances in Oncology available now!

pharmafile | September 30, 2016 | News story | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |  Pharmafocus, oncology, pharmafocus supplement 

The latest issue of Pharmafocus is now available, and with it comes Advances in Oncology, our supplement featuring all the latest in tumour research and treatment.

Inside you can find a range of valuable insight from industry experts. Anjali Shukla investigates checkpoint inhibitor drugs and how they may be paving a path to a cancer cure by influencing the human immune system, and Sean Murray speaks to Dr Ugur Sahin, CEO of BioNTech to discuss the rapidly approaching possibility of a universal cancer vaccine.

Also in the issue, AbbVie’s VP of oncology clinical development brings some encouraging signs from the blood cancer space, and Cancer Research UK’s Dr Rowena Sharp and Dr Catrin Middleton delve into the crucial area of precision medicine and how progress in the field is leading us ever-closer to truly personalised cancer care.

Advertisement

Related Content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

Bristol Myers Squibb (BMS) has announced that its Opdivo (nivolumab) has been accepted, in combination …

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

Astellas Pharma, a pharmaceutical company creating medicines to address unmet medical needs, has announced that …

Rethinking oncology trial endpoints with generalised pairwise comparisons

For decades, oncology trials have been anchored to a familiar set of endpoints. Overall survival …

The Gateway to Local Adoption Series

Latest content